Publication/Registration Details |
(1) 2024/19 Gaz on 2024-05-23
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for the treatment and/or
prevention of metabolic diseases, vascular diseases,
neurodegenerative diseases, skeletal diseases, mental
disorders and gastroenterological diseases; pharmaceutical
preparations for the treatment and/or prevention of
pre-diabetic conditions, insulin resistance, obesity, type 2
diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic
fatty liver disease, non-alcoholic steatohepatitis, type 2
diabetes, depression, motivational disorders, depressive
moods and malabsorption disorders; pharmaceutical
preparations for improving mood and mental and physical
wellbeing; food supplements and dietetic preparations for
the treatment and/or prevention of metabolic diseases,
vascular diseases, neurodegenerative diseases, skeletal
diseases, psychic disorders and gastroenterological
diseases; food supplements and dietary preparations for the
treatment and/or prevention of pre-diabetic states, insulin
resistance, obesity, type 2 diabetes, metabolic syndrome,
hyperlipidemia, non-alcoholic fatty liver, depression,
motivational disorders, depressed mood and malabsorption
disorders; food supplements and dietetic preparations for
improving mood and mental and physical wellbeing; all of the
above, with the exception of all goods consisting of,
containing or derived from cannabis, marijuana or hemp.
Class 42 -
Pharmaceutical research and development services;
biochemical research and development services; medical
research and development services; all of the above, with
the exception of services relating to all goods consisting
of, containing or derived from cannabis, marijuana or hemp.
|
Publication/Registration Details |
(1) 2024/15 Gaz on 2024-04-25
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for the treatment and/or
prevention of metabolic diseases, vascular diseases,
neurodegenerative diseases, skeletal diseases, psychic
disorders and gastroenterological diseases; pharmaceutical
preparations for the treatment and/or prevention of
pre-diabetic conditions, insulin resistance, obesity, type 2
diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic
fatty liver steatohepatitis, non-alcoholic steatohepatitis,
depression, motivational disorders, depressive moods, and
malabsorption disorders; pharmaceutical preparations for
improving mood and mental and physical wellbeing; food
supplements and dietetic preparations for the treatment
and/or prevention of metabolic diseases, vascular diseases,
neurodegenerative diseases, skeletal diseases, psychic
disorders and gastroenterological diseases; food supplements
and dietetic preparations for the treatment and/or
prevention of prediabetic conditions, insulin resistance,
obesity, type 2 diabetes, metabolic syndrome,
hyperlipidemia, non-alcoholic fatty liver steatohepatitis,
depression, motivational disorders, depressive moods and
malabsorption disorders; food supplements and dietetic
preparations for improving mood and mental and physical
wellbeing all of the foregoing excluding any goods that
consist of, contain or are derived from cannabis, marijuana
or hemp.
Class 42 -
Pharmaceutical research and development services;
biochemical research and development services; medical
research and development services; all of the foregoing
excluding services in relation to any goods that consist of,
contain or are derived from cannabis, marijuana or hemp.
|
Publication/Registration Details |
(1) 2023/52 Gaz on 2024-01-11
|
Designated Country Details
|
(1) US under Protocol
(2) DE under ProtocolArticle9-6
|